Status:
NOT_YET_RECRUITING
Assessment of CXCL5 Level in SLE Patients and Its Correlation with Disease Activity
Lead Sponsor:
Assiut University
Conditions:
SLE (Systemic Lupus)
Eligibility:
All Genders
18+ years
Brief Summary
Assessment of CXCL5 biomarker in Serum of patients of SLE in comparison to healthy patients and its correlation with disease activity
Detailed Description
Systemic lupus erythematosus (SLE) is a common autoimmune disease involving multiple organs and systems. SLE is characterized by the production of a large number of autoantibodies and the deposition o...
Eligibility Criteria
Inclusion
- Age \>18 years old
- Patients who are diagnosed as SLE according to the 2012 Systemic Lupus International Collaborating Clinics (SLICC) Citeria (10,11).
Exclusion
- age \< 18 years old
- Patients unwilling to participate in the study.
- Patients with other autoimmune diseases.
- Patients with malignancy or infections.
- Pregnancy and lactation
Key Trial Info
Start Date :
October 1 2024
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
September 30 2027
Estimated Enrollment :
90 Patients enrolled
Trial Details
Trial ID
NCT06610409
Start Date
October 1 2024
End Date
September 30 2027
Last Update
September 24 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Faculty of medicine Assiut University
Asyut, Dairuit, Egypt